Europe is home to some of the world’s top healthcare firms. Though all European countries have national healthcare systems, healthcare is still a big business worth billions of Euros. Drug firms for instance sell their products at a significant margin to health agencies. In addition, many European drug firms have substantial presence in emerging and …
Continue reading ‘A Look At The Top European Healthcare Companies’ »
Biotech stocks have declined heavily in the past few weeks. Up until recently stocks in this sector reached sky-high valuations as investors were highly attracted by the ever-rising stock prices. But now investors are getting second-thoughts and are selling stocks across the sector as fear of further declines takes hold. The iShares Nasdaq Biotechnology ETF (IBB) which …
Continue reading ‘Eight Points To Remember About Biotech Stocks’ »
High healthcare spending does not necessarily mean better health. Even with lower spending people can live healthier lives and live longer. Generally developed countries tend to high healthcare expenditures whether funded by the state or by private individuals. I came across the following charts showing the relationship between healthcare expenditures and life expectancy. Click to …
Continue reading ‘Relationship between Healthcare Spending and Health’ »
America is the only nation in history which miraculously has gone directly from barbarism to decadence without the usual interval of civilization. – Georges Clemenceau, French journalist, physician and statesman The U.S. health care system is actually a hodge-podge of many entities, some of which may have conflicting interests, meshed together to operate under the …
Continue reading ‘A Comparison of U.S. Health Care To Other Developed Countries’ »
The Pharmaceutical Executive magazine published earlier this year its annual ranking of the Top 50 Pharmaceutical Companies by revenue. The following table lists the top 25 global companies ranked based on sales in 2011: Source: Pharmaceutical Executive The top 50 companies accounted sold $610 billion in human prescription pharmaceuticals last year and just the top 10 accounted for 59% of the …
Continue reading ‘The Top 25 Global Pharmaceutical Companies by 2011 Sales’ »